Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10438 | 31336502 | Diabetes Metab Syndr | The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. | 2019 | Details |
| A10439 | 31336476 | Diabetes Metab Syndr | Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: A case control study. | 2019 | Details |
| A10440 | 31336445 | Diabetes Metab Syndr | Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2019 | Details |
| A10441 | 31336392 | J Gastroenterol Hepatol | Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10442 | 31336149 | Biochim Biophys Acta Mol Basis Dis | The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. | 2019 | Details |
| A10444 | 31334554 | J Nutr | A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk. | 2019 | Details |
| A10445 | 31334443 | Hepatol Commun | Influence of Fat on Differential Receptor Interacting Serine/Threonine Protein Kinase 1 Activity Leading to Apoptotic Cell Death in Murine Liver Ischemia Reperfusion Injury Through Caspase 8. | 2019 | Details |
| A10446 | 31334442 | Hepatol Commun | Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes. | 2019 | Details |
| A10447 | 31334441 | Hepatol Commun | Nocturnal Hypoxia Activation of the Hedgehog Signaling Pathway Affects Pediatric Nonalcoholic Fatty Liver Disease Severity. | 2019 | Details |
| A10448 | 31333877 | Clin Diabetes Endocrinol | Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time. | 2019 | Details |
| A10449 | 31333307 | World J Gastroenterol | Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets. | 2019 | Details |
| A10450 | 31332938 | Liver Int | Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis. | 2019 | Details |
| A10451 | 31332389 | Nat Med | Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. | 2019 | Details |
| A10452 | 31332029 | Diabetes Care | Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. | 2019 | Details |
| A10453 | 31330977 | Antioxidants (Basel) | Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review. | 2019 | Details |
| A10454 | 31330971 | J Clin Med | Serum Vitamin E Levels of Adults with Nonalcoholic Fatty Liver Disease: An Inverse Relationship with All-Cause Mortality in Non-Diabetic but Not in Pre-Diabetic or Diabetic Subjects. | 2019 | Details |
| A10455 | 31330553 | Semin Liver Dis | Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? | 2019 | Details |
| A10456 | 31330134 | Metabolism | AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. | 2019 | Details |
| A10457 | 31328300 | Aliment Pharmacol Ther | Depression is associated with non-alcoholic fatty liver disease among adults in the United States. | 2019 | Details |
| A10458 | 31328113 | Prev Nutr Food Sci | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10459 | 31328066 | Cureus | A Retrospective Study to Examine the Correlation of Bioelectrical Impedance Analysis with Shear-wave Elastography in Indian Patients with Non-alcoholic Fatty Liver Disease and Diabetes on Background Sodium-glucose Cotransporter-2 Inhibitor Therapy. | 2019 | Details |
| A10460 | 31327168 | Mol Nutr Food Res | Industrial Trans Fatty Acids Stimulate SREBP2-Mediated Cholesterogenesis and Promote Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10461 | 31326267 | J Diabetes Complications | Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. | 2019 | Details |
| A10462 | 31326093 | Am J Med Sci | Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group. | 2019 | Details |
| A10463 | 31325892 | J Nutr Biochem | Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. | 2019 | Details |
| A10464 | 31325714 | Environ Int | Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex. | 2019 | Details |
| A10465 | 31325638 | Biochim Biophys Acta Mol Cell Biol Lipids | Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. | 2019 | Details |
| A10467 | 31324878 | Int J Obes (Lond) | Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats. | 2019 | Details |
| A10468 | 31324247 | BMC Complement Altern Med | Evaluation of HuoXueHuaYu therapy for nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trial. | 2019 | Details |
| A10469 | 31324181 | Nutr J | The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial. | 2019 | Details |
| A10470 | 31324087 | J Assoc Physicians India | Effects of Canagliflozin on Abnormal Liver Function Tests in Patients of Type 2 Diabetes with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A10471 | 31323923 | Toxins (Basel) | Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats. | 2019 | Details |
| A10472 | 31322445 | Scand J Gastroenterol | Transient elastography: should XL probe be used in all overweight patients? | 2019 | Details |
| A10473 | 31322321 | Mol Nutr Food Res | A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10474 | 31322255 | Mol Med Rep | Adenovirus‑mediated overexpression of bone morphogenetic protein‑9 promotes methionine choline deficiency‑induced non‑alcoholic steatohepatitis in non‑obese mice. | 2019 | Details |
| A10475 | 31322211 | Mol Med Rep | Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21/fibroblast growth factor receptor 2/adiponectin pathway in HepG2 cells. | 2019 | Details |
| A10476 | 31321014 | Ther Adv Chronic Dis | Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. | 2019 | Details |
| A10477 | 31320150 | Ultrasound Med Biol | Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10478 | 31319896 | Clin Epigenetics | Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. | 2019 | Details |
| A10480 | 31319186 | Clin Gastroenterol Hepatol | Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia. | 2019 | Details |
| A10481 | 31318914 | PLoS One | Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. | 2019 | Details |
| A10483 | 31317132 | EClinicalMedicine | Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians. | 2019 | Details |
| A10484 | 31316716 | Oxid Med Cell Longev | Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model. | 2019 | Details |
| A10485 | 31316594 | Exp Ther Med | Effect of resveratrol on non-alcoholic fatty liver disease. | 2019 | Details |
| A10486 | 31315613 | BMC Endocr Disord | The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. | 2019 | Details |
| A10487 | 31315327 | J Assoc Physicians India | Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease. | 2018 | Details |
| A10488 | 31315223 | Nutrients | Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver. | 2019 | Details |
| A10492 | 31312990 | Dig Dis Sci | Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. | 2019 | Details |
| A10493 | 31312893 | Abdom Radiol (NY) | Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease. | 2019 | Details |
| A10494 | 31311600 | BMC Med | GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. | 2019 | Details |
| A10495 | 31311491 | BMC Gastroenterol | Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. | 2019 | Details |
| A10496 | 31311339 | Arch Physiol Biochem | The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model. | 2019 | Details |
| A10497 | 31311301 | FASEB J | Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway. | 2019 | Details |
| A10498 | 31311123 | Nutrients | Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis. | 2019 | Details |
| A10501 | 31310032 | J Gastroenterol Hepatol | Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease. | 2019 | Details |
| A10502 | 31309820 | Curr Vasc Pharmacol | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. | 2019 | Details |
| A10503 | 31309745 | Mol Genet Genomic Med | The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects. | 2019 | Details |
| A10504 | 31309602 | Hepatology | Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10505 | 31309589 | Hepatology | Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. | 2019 | Details |
| A10506 | 31309533 | FEBS Lett | Chronic exposure to Pb2+ perturbs ChREBP transactivation and coerces hepatic dyslipidemia. | 2019 | Details |
| A10507 | 31308717 | Diabetes Metab Syndr Obes | Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway. | 2019 | Details |
| A10508 | 31308716 | Diabetes Metab Syndr Obes | SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions. | 2019 | Details |
| A10509 | 31308686 | Nutr Metab Insights | Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. | 2019 | Details |
| A10510 | 31308634 | Drug Des Devel Ther | The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. | 2019 | Details |
| A10511 | 31308382 | Sci Rep | Natural course of fatty liver in 36,195 South Korean adults. | 2019 | Details |
| A10512 | 31308341 | Intern Med | The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10513 | 31307925 | Obes Res Clin Pract | Nonalcoholic fatty liver disease does not predict worse perioperative outcomes in bariatric surgery. | 2019 | Details |
| A10514 | 31307592 | Adv Pharmacol | Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. | 2019 | Details |
| A10515 | 31307427 | BMC Gastroenterol | A new method to induce nonalcoholic steatohepatitis (NASH) in mice. | 2019 | Details |
| A10516 | 31306673 | Toxicol Appl Pharmacol | Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. | 2019 | Details |
| A10517 | 31305280 | J Clin Gastroenterol | CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness. | 2020 | Details |
| A10518 | 31305223 | J Am Coll Nutr | Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10519 | 31305201 | Metab Syndr Relat Disord | The Effect of Low Glycemic Index and Glycemic Load Diets on Hepatic Fat Mass, Insulin Resistance, and Blood Lipid Panels in Individuals with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10520 | 31304703 | J Assoc Physicians India | Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? | 2019 | Details |
| A10521 | 31304450 | Hepatol Commun | Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice. | 2019 | Details |
| A10522 | 31303681 | J Okla State Med Assoc | Overview of Pediatric Nonalcoholic Fatty Liver Disease: A Guide for General Practitioners. | 2018 | Details |
| A10523 | 31301418 | Life Sci | (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. | 2019 | Details |
| A10525 | 31301321 | J Hepatol | Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. | 2019 | Details |
| A10526 | 31301251 | Clin Endocrinol (Oxf) | Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index). | 2019 | Details |
| A10528 | 31300805 | Sci Rep | Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease. | 2019 | Details |
| A10529 | 31300518 | Gut | miRNAs and NAFLD: from pathophysiology to therapy. | 2019 | Details |
| A10531 | 31300231 | J Hepatol | Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD. | 2019 | Details |
| A10532 | 31299271 | Toxicol Appl Pharmacol | IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A10533 | 31299062 | PLoS One | AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p. | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10536 | 31297627 | Dig Dis Sci | A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. | 2019 | Details |
| A10537 | 31296161 | BMC Gastroenterol | Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. | 2019 | Details |
| A10538 | 31295962 | J Clin Med | Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels. | 2019 | Details |
| A10539 | 31294345 | J Obes Metab Syndr | Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10540 | 31293912 | J Clin Transl Hepatol | Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. | 2019 | Details |
| A10541 | 31293910 | J Clin Transl Hepatol | Metabolic Acidosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury. | 2019 | Details |
| A10542 | 31293908 | J Clin Transl Hepatol | Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population. | 2019 | Details |
| A10544 | 31293521 | Front Endocrinol (Lausanne) | The Nuclear Receptor-Co-repressor Complex in Control of Liver Metabolism and Disease. | 2019 | Details |
| A10545 | 31293441 | Front Physiol | The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10546 | 31293341 | World J Gastroenterol | Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10547 | 31293337 | World J Gastroenterol | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A10548 | 31293335 | World J Gastroenterol | Immunotherapy for hepatocellular carcinoma: Current and future. | 2019 | Details |
| A10549 | 31293021 | Phytother Res | The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A10550 | 31292843 | Clin J Gastroenterol | Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |